Source: Virtual Congress 2020 – Clinical management of lung transplant recipients



Rating:

Share or cite this content

Citations should be made in the following way:
E. Revilla Lopez (Barcelona, Spain), M. Jarque (Barcelona, Spain), B. Sáez Giménez (Barcelona, Spain), I. Los Arcos (Barcelona, Spain), S. Gómez Ollés (Barcelona, Spain), O. Bestard (Barcelona, Spain), C. Bravo (Barcelona, Spain), V. Monforte (Barcelona, Spain). Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation. 1939

Member's Comments

No comment yet.

Related content which might interest you: T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 How infections can modify lung immunity Source: Eur Respir J 2001; 18: 442-443 Year: 2001 How infections can modify lung immunity Source: Guideline 2001 Year: 2001 The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005 Anti-endotoxin humoral immunity in patients with pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Influence of innate immunity on respiratory disease development and vaccination process Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006 The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments Source: Eur Respir Rev 2015; 24: 356-360 Year: 2015 The humoral immune response to influenza vaccination in lung transplant patients Source: Eur Respir J 2001; 18: 971-976 Year: 2001 Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae Source: ERJ Open Res, 8 (1) 00706-2021; 10.1183/23120541.00706-2021 Year: 2022 Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome Source: Eur Respir J 2011; 37: 1248-1259 Year: 2011 Assessment of humoral immune response and the incidence of acquired infections in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 Latent tuberculosis infection treatment in subjects with autoimmune diseases and T-cell interferon-γ responses Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 MAIT cells contribute to a protective antiviral innate response to influenza infection Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018